Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript


Image source: The Motley Fool.

Vertex Pharmaceuticals (NASDAQ: VRTX)
Q2 2023 Earnings Call
Aug 01, 2023, 4:30 p.m. ET

Operator

Continue reading


Source Fool.com

Vertex Pharmaceuticals Inc. Stock

€460.15
1.030%
There is an upward development for Vertex Pharmaceuticals Inc. compared to yesterday, with an increase of €4.70 (1.030%).
With 55 Buy predictions and 2 Sell predictions Vertex Pharmaceuticals Inc. is one of the favorites of our community.
However, we have a potential of -2.21% for Vertex Pharmaceuticals Inc. as the target price of 450 € is below the current price of 460.15 €.
Like: 0
Share

Comments